Background and objective
Stroke is a devastating condition with long-term comorbidities including metabolic abnormalities. Alpha lipoic acid (ALA), with its antioxidant properties, might improve metabolic status of patients, though current evidence is still inclusive. This systematic review of randomized controlled trials (RCTs) was conducted to summarize the existing evidence regarding the effects of ALA supplementation on fasting glucose and lipid profiles among patients with stroke.
We searched Cochrane Library, EMBASE, MEDLINE, and Web of Science from 1990 until April 5th, 2018. The relevant randomized-controlled articles, based on defined key words, were included in the analyses. Two independent researchers investigated study eligibility, extracted data, and assessed the risk of bias for included studies. Heterogeneity among included studies was tested using Q-test and I2 statistics. Random-effects models were applied to pool the data and standardized mean differences (WMD) were considered as summary effect size.
A total of five studies (140 patients in each intervention group) were included in our meta-analysis. The findings showed that ALA supplementation significantly decreased fasting glucose levels (WMD −36.93 mg/dL; 95% CI, −65.58, −8.28; P = 0.01; I2 = 85.0%) in patients with stroke. We found no significant effect of ALA supplementation on triglycerides (WMD −7.45 mg/dL; 95% CI, −51.35, 36.45; P = 0.739; I2 = 83.9%), total cholesterol (WMD −23.23 mg/dL; 95% CI, −48.07, 1.62; P = 0.067; I2 = 80.5%), LDL-cholesterol (WMD −10.46 mg/dL; 95% CI, −21.01, 0.09; P = 0.052; I2 = 47.4%) and HDL-cholesterol levels (WMD −3.02 mg/dL; 95% CI, −20.18, 14.14; P = 0.730; I2 = 85.8%).
This meta-analysis suggested the beneficial impacts of ALA supplementation in improving fasting glucose of patients diagnosed with stroke.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
The primary data for this study is available from the authors on direct request.
Low density lipoprotein-cholesterol
High density lipoprotein-cholesterol
Vasiliadis AV, Zikic M. Current status of stroke epidemiology in Greece: a panorama. Neurol Neurochir Pol. 2014;48:449–57.
Jauch EC, Saver JL, Adams HP, Jr., Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.
Deb P, Sharma S, Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology. 2010;17:197–218.
Zhao NN, Zeng KX, Wang YL, Sheng PJ, Tang CZ, Xiao P, et al. Research on the nutrition and cognition of high-risk stroke groups in community and the relevant factors. Eur Rev Med Pharmacol Sci. 2017;21:5408–14.
Santoro L, De Matteis G, Fuorlo M, Giupponi B, Martone AM, Landi F, et al. Atherosclerosis and cardiovascular involvement in celiac disease: the role of autoimmunity and inflammation. Eur Rev Med Pharmacol Sci. 2017;21:5437–44.
Manzanero S, Santro T, Arumugam TV. Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int. 2013;62:712–8.
Hanafy KA, Selim MH. Antioxidant strategies in neurocritical care. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2012;9:44–55.
Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke. 1991;22:312–8.
MacMahon S, Rodgers A. Blood pressure, antihypertensive treatment and stroke risk. J Hypertens Suppl. 1994;12:S5–14.
Zhong LL, Ding LS, He W, Tian XY, Cao H, Song YQ, et al. Systolic hypertension related single nucleotide polymorphism is associated with susceptibility of ischemic stroke. Eur Rev Med Pharmacol Sci. 2017;21:2901–6.
Liu J, Yang H, Yu B. The correlation between blood calcium level, hematoma volume, stroke severity and prognosis in patients with acute cerebral hemorrhage. Eur Rev Med Pharmacol Sci. 2016;20:4119–23.
Seifar F, Khalili M, Khaledyan H, Amiri Moghadam S, Izadi A, Azimi A, et al. Alpha-lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: a review. Nutr Neurosci. 2017:1–11.
Zhao L, Hu FX. Alpha-lipoic acid treatment of aged type 2 diabetes mellitus complicated with acute cerebral infarction. Eur Rev Med Pharmacol Sci. 2014;18:3715–9.
Mohammadi V, Khorvash F, Feizi A, Askari G. Does alpha-lipoic acid comsumption improve lipid profile in patients with stroke? A randomized, double blind, placebo-controlled clinical trial. Iranian Red Crescent Med J. 2017;19.
Ansar H, Mazloom Z, Kazemi F, Hejazi N. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J. 2011;32:584–8.
Huerta AE, Navas-Carretero S, Prieto-Hontoria PL, Martinez JA, Moreno-Aliaga MJ. Effects of alpha-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss. Obesity (Silver Spring). 2015;23:313–21.
Okanovic A, Prnjavorac B, Jusufovic E, Sejdinovic R. Alpha-lipoic acid reduces body weight and regulates triglycerides in obese patients with diabetes mellitus. Med Glas (Zenica). 2015;12:122–7.
Li N, Yan W, Hu X, Huang Y, Wang F, Zhang W, et al. Effects of oral alpha-lipoic acid administration on body weight in overweight or obese subjects: a crossover randomized, double-blind, placebo-controlled trial. Clin Endocrinol. 2017;86:680–7.
de Oliveira AM, Rondo PH, Luzia LA, D'Abronzo FH, Illison VK. The effects of lipoic acid and alpha-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Diabetes Res Clin Pract. 2011;92:253–60.
Manolescu BN, Berteanu M, Cinteza D. Effect of the nutritional supplement ALAnerv(R) on the serum PON1 activity in post-acute stroke patients. Pharmacol Rep. 2013;65:743–50.
Chapman K. Can people make healthy changes to their diet and maintain them in the long term? A review of the evidence. Appetite. 2010;54:433–41.
Roumen C, Blaak EE, Corpeleijn E. Lifestyle intervention for prevention of diabetes: determinants of success for future implementation. Nutr Rev. 2009;67:132–46.
Tabrizi R, Akbari M, Moosazadeh M, Lankarani KB, Heydari ST, Kolahdooz F, et al. The effects of selenium supplementation on glucose metabolism and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Horm Metab Res. 2017;49(11):826–30.
Andrade VH, Mata AM, Borges RS, Costa-Silva DR, Martins LM, Ferreira PM, et al. Current aspects of polycystic ovary syndrome: a literature review. Rev Assoc Med Bras (1992). 2016;62:867–71.
Tabatabaei-Malazy O, Nikfar S, Larijani B, Abdollahi M. Influence of ascorbic acid supplementation on type 2 diabetes mellitus in observational and randomized controlled trials; a systematic review with meta-analysis. J Pharm Pharm Sci. 2014;17:554–82.
Suksomboon N, Poolsup N, Juanak N. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis. J Clin Pharm Ther. 2015;40:413–8.
Karadag C, Yoldemir T, Yavuz DG. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients. J Obstet Gynaecol Res. 2017.
Hoseini R, Damirchi A, Babaei P. Vitamin D increases PPARgamma expression and promotes beneficial effects of physical activity in metabolic syndrome. Nutrition. 2017;36:54–9.
Mirmasoumi G, Fazilati M, Foroozanfard F, Vahedpoor Z, Mahmoodi S, Taghizadeh M, et al. The effects of flaxseed oil omega-3 fatty acids supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2018;126(4):222–8.
Khabbazi T, Mahdavi R, Safa J, Pour-Abdollahi P. Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. J Ren Nutr. 2012;22:244–50.
Qu F, Wang FF, Yin R, Ding GL, El-Prince M, Gao Q, et al. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med (Berl). 2012;90:911–23.
Irani M, Seifer DB, Grazi RV, Irani S, Rosenwaks Z, Tal R. Vitamin D decreases serum VEGF correlating with clinical improvement in vitamin D-deficient women with PCOS: a randomized placebo-controlled trial. Nutrients. 2017;9.
Khani B, Mardanian F, Fesharaki SJ. Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. J Res Med Sci. 2017;22:64.
Carrier B, Wen S, Zigouras S, Browne RW, Li Z, Patel MS, et al. Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese Zucker rats. PLoS One. 2014;9:e90863.
Oprea E, Berteanu M, Cinteza D, Manolescu BN. The effect of the ALAnerv nutritional supplement on some oxidative stress markers in postacute stroke patients undergoing rehabilitation. Appl Physiol Nutr Metab. 2013;38:613–20.
Mohammadi V, Khorvash F, Feizi A, Askari G. Does alpha-lipoic acid supplementation modulate cardiovascular risk factors in patients with stroke? A randomized, double-blind clinical trial. Int J Prev Med. 2018;9:34. https://doi.org/10.4103/ijpvm.IJPVM_32_17.
The present study was supported by a grant (no. 97-01-106-17829) from the Vice-chancellor for Research, SUMS, Shiraz, and Iran.
The research grant provided by Research Deputy of Shiraz University of Medical Sciences (SUMS).
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.
Consent for publication
The authors declare no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tabrizi, R., Borhani-Haghighi, A., Mirhosseini, N. et al. The effects of alpha-lipoic acid supplementation on fasting glucose and lipid profiles among patients with stroke: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord 18, 585–595 (2019). https://doi.org/10.1007/s40200-019-00423-0
- Alpha-lipoic acid
- Lipid profiles